Solventum Corporation SOLV

89.50 0.91 1.03% as of 25 Sep
Market cap
$15.1B
P/E
10.9×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Solventum Corporation (SOLV) P/B ratio

As of 25 September 2026, Solventum Corporation (SOLV) trades at a P/B ratio of 3.2×. Over the past ten years it has ranged from 1.0× (March 2024) to 4.9× (February 2025); the current reading is higher than 50% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 2.7× (29.35%)
FY2024 3.9× 226.50%
FY2023 1.2× 0.00%
FY2022 1.2× —

Quarterly

Period P/B ratio Change
Jun 2026 2.8× 21.30%
Mar 2026 2.3× (16.22%)
Dec 2025 2.7× 7.05%
Sep 2025 2.6× (29.55%)
10 more quarters

Against its own ten years

Low 1.0× High 4.9×
Ten-year median 3.2×
Current reading's percentile 50

P/B ratio against peers

Company P/B ratio
COO The Cooper Companies, Inc. compare 1.3×
ALC Alcon compare 1.5×
AVTR Avantor, Inc. compare 1.8×
BAX Baxter International Inc. compare 2.0×
ALGN Align Technology, Inc. compare 2.5×
ATR AptarGroup, Inc. compare 3.0×
SOLV Solventum Corporation 3.2×
RGEN Repligen Corporation compare 5.1×
WST West Pharmaceutical Services, Inc. compare 8.8×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on SOLV